Literature DB >> 2896254

P-fimbriae receptors in patients with chronic pyelonephritis.

S H Jacobson1, G Källenius, L E Lins, S B Svenson.   

Abstract

The adherence of fluorescein isothiocyanate-labeled P-fimbriated Escherichia coli to uroepithelial cells from 19 women with chronic pyelonephritis was determined with the fluorescence-activated cell sorting technique. The application of this method has made it possible to study bacterial binding to a large number of cells. Renal function was determined in all patients and the recurrences of P-fimbriated Escherichia coli bacteriuria, cystitis and acute pyelonephritis during a 3-year followup were studied. We found a significant correlation between the P-fimbriae receptor accessibility on uroepithelial cells and glomerular filtration rate (r equals -0.75, p less than 0.001). Uroepithelial cells from the patients with chronic pyelonephritis and renal insufficiency had a higher binding capacity of P-fimbriated Escherichia coli than uroepithelial cells from patients with a normal glomerular filtration rate. There was no correlation between kidney function and the availability of P-fimbriae receptors in a control group of patients with polycystic kidney disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896254     DOI: 10.1016/s0022-5347(17)42710-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.

Authors:  S H Jacobson; O Eklöf; C G Eriksson; L E Lins; B Tidgren; J Winberg
Journal:  BMJ       Date:  1989-09-16

Review 2.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.

Authors:  J A Roberts; B I Marklund; D Ilver; D Haslam; M B Kaack; G Baskin; M Louis; R Möllby; J Winberg; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.